CN101559168B - Pharmaceutical composition for invigorating Qi, tonifying blood and nourishing liver and kidney as well as preparation method and application thereof - Google Patents
Pharmaceutical composition for invigorating Qi, tonifying blood and nourishing liver and kidney as well as preparation method and application thereof Download PDFInfo
- Publication number
- CN101559168B CN101559168B CN2008101042487A CN200810104248A CN101559168B CN 101559168 B CN101559168 B CN 101559168B CN 2008101042487 A CN2008101042487 A CN 2008101042487A CN 200810104248 A CN200810104248 A CN 200810104248A CN 101559168 B CN101559168 B CN 101559168B
- Authority
- CN
- China
- Prior art keywords
- filtrating
- ethanol
- filter
- pharmaceutical composition
- subsequent use
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000008280 blood Substances 0.000 title claims abstract description 26
- 210000004369 blood Anatomy 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 210000003734 kidney Anatomy 0.000 title claims abstract description 17
- 210000004185 liver Anatomy 0.000 title claims abstract description 16
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 76
- 239000002994 raw material Substances 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 122
- 239000007788 liquid Substances 0.000 claims description 56
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- 229940079593 drug Drugs 0.000 claims description 25
- 230000001105 regulatory effect Effects 0.000 claims description 20
- 239000009636 Huang Qi Substances 0.000 claims description 19
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 17
- 238000012360 testing method Methods 0.000 claims description 13
- 239000006187 pill Substances 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 9
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 7
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 7
- 239000013558 reference substance Substances 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- 230000036039 immunity Effects 0.000 claims description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- 239000004952 Polyamide Substances 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 239000003480 eluent Substances 0.000 claims description 4
- 229920002647 polyamide Polymers 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 3
- 230000000242 pagocytic effect Effects 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 241000545442 Radix Species 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000000945 filler Substances 0.000 claims description 2
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 2
- 238000004321 preservation Methods 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- 238000011003 system suitability test Methods 0.000 claims description 2
- 238000004811 liquid chromatography Methods 0.000 claims 1
- 230000036541 health Effects 0.000 abstract description 3
- 210000004072 lung Anatomy 0.000 abstract description 3
- 239000000047 product Substances 0.000 abstract description 3
- 210000000952 spleen Anatomy 0.000 abstract description 3
- 239000000686 essence Substances 0.000 abstract description 2
- 241000893536 Epimedium Species 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 244000182216 Mimusops elengi Species 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 32
- 241000699670 Mus sp. Species 0.000 description 22
- 239000000243 solution Substances 0.000 description 21
- 230000000694 effects Effects 0.000 description 16
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 12
- 210000004556 brain Anatomy 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 230000002490 cerebral effect Effects 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 238000001035 drying Methods 0.000 description 6
- 239000011521 glass Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000006196 drop Substances 0.000 description 5
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 4
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 210000004209 hair Anatomy 0.000 description 4
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 3
- 201000004384 Alopecia Diseases 0.000 description 3
- 206010011878 Deafness Diseases 0.000 description 3
- 206010024264 Lethargy Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 231100000360 alopecia Toxicity 0.000 description 3
- 230000002929 anti-fatigue Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 206010027175 memory impairment Diseases 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000001291 vacuum drying Methods 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 229960003638 dopamine Drugs 0.000 description 2
- 239000000890 drug combination Substances 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- AZHSSKPUVBVXLK-UHFFFAOYSA-N ethane-1,1-diol Chemical compound CC(O)O AZHSSKPUVBVXLK-UHFFFAOYSA-N 0.000 description 2
- 238000012869 ethanol precipitation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 229960002748 norepinephrine Drugs 0.000 description 2
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 2
- 235000021590 normal diet Nutrition 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 2
- 229910001948 sodium oxide Inorganic materials 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 241001061264 Astragalus Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010049565 Muscle fatigue Diseases 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- -1 filter Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 235000010603 pastilles Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (4)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210365701.6A CN102836340B (en) | 2008-04-17 | 2008-04-17 | A kind of vigorate qi and replenish the blood, nourishing the liver and kidney pharmaceutical composition and its production and use |
CN2008101042487A CN101559168B (en) | 2008-04-17 | 2008-04-17 | Pharmaceutical composition for invigorating Qi, tonifying blood and nourishing liver and kidney as well as preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101042487A CN101559168B (en) | 2008-04-17 | 2008-04-17 | Pharmaceutical composition for invigorating Qi, tonifying blood and nourishing liver and kidney as well as preparation method and application thereof |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210365701.6A Division CN102836340B (en) | 2008-04-17 | 2008-04-17 | A kind of vigorate qi and replenish the blood, nourishing the liver and kidney pharmaceutical composition and its production and use |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101559168A CN101559168A (en) | 2009-10-21 |
CN101559168B true CN101559168B (en) | 2012-11-21 |
Family
ID=41218259
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210365701.6A Active CN102836340B (en) | 2008-04-17 | 2008-04-17 | A kind of vigorate qi and replenish the blood, nourishing the liver and kidney pharmaceutical composition and its production and use |
CN2008101042487A Active CN101559168B (en) | 2008-04-17 | 2008-04-17 | Pharmaceutical composition for invigorating Qi, tonifying blood and nourishing liver and kidney as well as preparation method and application thereof |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210365701.6A Active CN102836340B (en) | 2008-04-17 | 2008-04-17 | A kind of vigorate qi and replenish the blood, nourishing the liver and kidney pharmaceutical composition and its production and use |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN102836340B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103083545B (en) * | 2013-02-17 | 2015-08-12 | 成都地奥集团天府药业股份有限公司 | The purposes of Huo-Lisu oral liquor synergistic tandospirone or its salts for treating anxiety |
CN104069188B (en) * | 2013-03-29 | 2016-03-23 | 成都地奥集团天府药业股份有限公司 | Chinese medicine composition of a kind of Cure of depression and preparation method thereof |
CN104069189B (en) * | 2013-03-29 | 2016-03-23 | 成都地奥集团天府药业股份有限公司 | A kind of novelty teabag of Chinese medicine composition |
CN103446497A (en) * | 2013-07-30 | 2013-12-18 | 魏光春 | Production process of compound wine for tonifying kidney and producing sperms of men and improving memory |
CN103989936B (en) * | 2014-05-22 | 2017-05-03 | 彭小菊 | Solution for conditioning sub-health and preparation method thereof |
CN103977135A (en) * | 2014-06-11 | 2014-08-13 | 薛童 | Traditional Chinese medicinal composition for tonifying liver and kidney of middle-aged and old people and preparation method thereof |
CN104324225A (en) * | 2014-11-13 | 2015-02-04 | 滨州市知识产权维权援助中心 | Traditional Chinese medicine composition for reinvigorating body resistance and reinforcing kidney and application method thereof |
CN108295160A (en) * | 2018-04-20 | 2018-07-20 | 陈婷 | A kind of Traditional Chinese medicine foot bath side and preparation method thereof for improving immunity |
CN111375010A (en) * | 2020-03-19 | 2020-07-07 | 兰州大学第一医院 | A Chinese medicinal composition with effects of strengthening body resistance, consolidating constitution, nourishing liver, invigorating kidney, and enhancing immunity |
CN111558015A (en) * | 2020-05-13 | 2020-08-21 | 云南省中医医院(云南中医药大学第一附属医院) | A Chinese medicinal composition for treating alopecia |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1362101A (en) * | 2001-01-05 | 2002-08-07 | 杨孟君 | Nano Huolisu medicine for restoring vitality and its preparation |
-
2008
- 2008-04-17 CN CN201210365701.6A patent/CN102836340B/en active Active
- 2008-04-17 CN CN2008101042487A patent/CN101559168B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1362101A (en) * | 2001-01-05 | 2002-08-07 | 杨孟君 | Nano Huolisu medicine for restoring vitality and its preparation |
Non-Patent Citations (5)
Title |
---|
."活力苏"对人体脑血流图和动脉血压影响的观察.《四川生理科学杂志》.1986,36. |
杨纪曾 |
杨纪曾;汪世安;."活力苏"对人体脑血流图和动脉血压影响的观察.《四川生理科学杂志》.1986,36. * |
汪世安 |
药典委员会.活力苏口服液.《卫生部颁中药标准(成方制剂17册)》.1998,Z17-183. * |
Also Published As
Publication number | Publication date |
---|---|
CN102836340B (en) | 2015-08-12 |
CN102836340A (en) | 2012-12-26 |
CN101559168A (en) | 2009-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101559168B (en) | Pharmaceutical composition for invigorating Qi, tonifying blood and nourishing liver and kidney as well as preparation method and application thereof | |
EP4205748A1 (en) | Composition of ginsenosides rg3 and rg5 and anti-tumor pharmaceutical use thereof | |
CN103355655A (en) | Composition with alimentary anemia improving function and preparation method of composition | |
CN101019645B (en) | Health food for remitting fatigue and raising hypoxia tolerance and its preparation method | |
CN106723015A (en) | A kind of health food and its preparation technology with antifatigue and anti-oxidation function | |
CN114344351A (en) | Selenium-rich ganoderma lucidum spore powder capsule and preparation method thereof | |
CN107308323B (en) | Brain-nourishing oral liquid and its preparation process | |
CN105796861A (en) | Application of forsythin, forsythin derivatives and composition of forsythin and forsythiaside to preparation of drug for improving immune function | |
CN108813610A (en) | A kind of saussurea involucrata composition and its application for improving immunity | |
CN112617196A (en) | Food, health-care product or pharmaceutical composition for resisting anoxia and fatigue and preparation method and application thereof | |
CN102784230B (en) | Pharmaceutical composition preparation for treating nutritional anemia | |
CN114794478A (en) | Composition capable of reducing blood pressure, blood fat and blood sugar and application thereof | |
CN101199669A (en) | Chinese medicine compound agent for treating female sperm quality lowclass | |
CN103656164A (en) | Traditional Chinese medicine composition for nourishing yin, nourishing blood, tonifying heart and soothing nerves and preparation method thereof | |
CN108066350A (en) | The application of forsythin, its derivative, forsythin and phillygenol composition in prevention, treatment senile dementia is prepared | |
CN103169072A (en) | Ginseng composition, and preparation method and use thereof | |
CN103071080B (en) | Traditional Chinese medicine preparation for treating depressive disorder | |
CN106387915B (en) | Qi and coffee vigor-benefiting effervescent tablet and preparation process and application thereof | |
CN102949681B (en) | Composition for preventing or treating colds, and its preparation method | |
CN100423773C (en) | Application of edestin in preparation of medicament | |
CN110664905A (en) | Traditional Chinese medicine preparation for expelling wind and clearing away cold and preparation method thereof | |
CN104906339B (en) | It is a kind of that there is the health food granule for improving sleep function | |
CN105168519B (en) | With the composition and its preparation method and application for improving sleep function | |
CN103751692B (en) | Special invigorating capsule of a kind of Testis et penis callorhini and preparation method thereof | |
CN103494916A (en) | Traditional Chinese medicine composition with effect of reducing blood sugar, as well as preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20151009 Address after: 635000 Dazhou City, Sichuan Province Jian min Lu, Tongchuan District No. 96 Patentee after: Chengdu Diao Group Tianfu Medicine Co., Ltd. Patentee after: Chengdu Huanshen Group Co., Ltd. Address before: 635000 Dazhou City, Sichuan Province Jian min Lu, Tongchuan District No. 96 Patentee before: Chengdu Diao Group Tianfu Medicine Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 635000 Dazhou City, Sichuan Province Jian min Lu, Tongchuan District No. 96 Co-patentee after: Chengdu Thai Health Technology Group Limited by Share Ltd Patentee after: Chengdu Diao Group Tianfu Medicine Co., Ltd. Address before: 635000 Dazhou City, Sichuan Province Jian min Lu, Tongchuan District No. 96 Co-patentee before: Chengdu Huanshen Group Co., Ltd. Patentee before: Chengdu Diao Group Tianfu Medicine Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 635000 Dazhou City, Sichuan Province Jian min Lu, Tongchuan District No. 96 Co-patentee after: Chengdu Huashen Technology Group Co., Ltd Patentee after: CHENGDU DIAO GROUP TIANFU PHARMACEUTICAL Co.,Ltd. Address before: 635000 Dazhou City, Sichuan Province Jian min Lu, Tongchuan District No. 96 Co-patentee before: Chengdu Taihe Health Technology Group Co.,Ltd. Patentee before: CHENGDU DIAO GROUP TIANFU PHARMACEUTICAL Co.,Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20091021 Assignee: Pharmaceutical factory of Chengdu Huashen Technology Group Co.,Ltd. Assignor: Chengdu Huashen Technology Group Co.,Ltd. Contract record no.: X2021510000021 Denomination of invention: The invention relates to a pharmaceutical composition for supplementing qi and blood and nourishing liver and kidney, and a preparation method and application thereof Granted publication date: 20121121 License type: Common License Record date: 20210714 |